Author

Vivek Iyer

Observed names: Iyer, Vivek, Iyer, Vivek N, V. Iyer, V. N. Iyer, V.N. Iyer, VIVEK IYER, VIVEK N. IYER, Vivek N Iyer, Vivek N. Iyer, vivek N. iyer, vivek iyer

Observed institutions: University of North Carolina at Chapel Hill, Mayo Clinic, Johns Hopkins University, RTI International, Wayne State University, Medical College of Wisconsin, University of Utah, Detroit Medical Center, University of Florida, University of California San Diego, Massachusetts General Hospital, Mayo Clinic in Florida, Institute for Clinical Evaluative Sciences, Pulmonary and Critical Care Associates, University of Pennsylvania

ORCID: 0000-0001-6441-9319

Observed ORCID: 0000-0001-6441-9319

OpenAlex ID: A5073712726

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

· ATTACC Investigators, ACTIV-4a Investigators, et al. · Bern Open Repository and Information System (University of Bern) · 581

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia

2020 · Marie E. Faughnan, Johannes J. Mager, et al. · Annals of Internal Medicine · 539

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

2020 · Jaclyn A Smith, Michael M Kitt, et al. · The Lancet Respiratory Medicine · 234

PDF

Validity of the FOUR Score Coma Scale in the Medical Intensive Care Unit

2009 · Vivek N. Iyer, Jayawant N. Mandrekar, et al. · Mayo Clinic Proceedings · 199

PDF

Incidence and Temporal Trends of Primary Immunodeficiency: A Population-Based Cohort Study

2009 · Avni Y. Joshi, Vivek N. Iyer, et al. · Mayo Clinic Proceedings · 165

Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era

2012 · Vivek N. Iyer, Karen L. Swanson, et al. · Hepatology · 164

PDF

Spontaneous Pneumomediastinum: Analysis of 62 Consecutive Adult Patients

2009 · Vivek N. Iyer, Avni Y. Joshi, et al. · Mayo Clinic Proceedings · 163

PDF

An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study

2020 · Hanny Al-Samkari, Raj S. Kasthuri, et al. · Haematologica · 158

PDF

Propofol infusion syndrome in patients with refractory status epilepticus: An 11-year clinical experience*

2009 · Vivek N. Iyer, Rebecca Hoel, et al. · Critical Care Medicine · 155

Safety and Efficacy of Ambrisentan for the Treatment of Portopulmonary Hypertension

2010 · Rodrigo Cartin-Ceba, Karen Swanson, et al. · CHEST Journal · 137

Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding

2018 · Vivek N. Iyer, Dinesh R. Apala, et al. · Mayo Clinic Proceedings · 127

The Nonspecific Pulmonary Function Test

2010 · Vivek N. Iyer, Darrell R. Schroeder, et al. · CHEST Journal · 116

Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis

2016 · Waleed Brinjikji, Vivek N. Iyer, et al. · Journal of neurosurgery · 103

PDF

Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19

2023 · Ewan C. Goligher, Patrick R. Lawler, et al. · JAMA · 101

PDF

Global Physiology and Pathophysiology of Cough

2020 · Kai K. Lee, Paul W. Davenport, et al. · CHEST Journal · 93

PDF

Ketamine/propofol admixture vs etomidate for intubation in the critically ill: KEEP PACE Randomized clinical trial

2019 · Nathan Jerome Smischney, Wayne T. Nicholson, et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 93

Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis

2013 · Elizabeth J. Carey, Vivek N. Iyer, et al. · Liver Transplantation · 86

PDF

Hemorrhage Rates From Brain Arteriovenous Malformation in Patients With Hereditary Hemorrhagic Telangiectasia

2015 · Helen Kim, Jeffrey Nelson, et al. · Stroke · 69

PDF

Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency

2017 · Stella Hartono, Megan S. Motosue, et al. · Annals of Allergy Asthma & Immunology · 68

Development and performance of a novel vasopressor-driven mortality prediction model in septic shock

2018 · Saraschandra Vallabhajosyula, Jacob C. Jentzer, et al. · Annals of Intensive Care · 62

PDF

Cerebrovascular Manifestations of Hereditary Hemorrhagic Telangiectasia

2015 · Waleed Brinjikji, Vivek N. Iyer, et al. · Stroke · 56

Fetal outcomes of critically ill pregnant women admitted to the intensive care unit for nonobstetric causes*

2008 · Rodrigo Cartin-Ceba, Ognjen Gajic, et al. · Critical Care Medicine · 54

Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival

2015 · Lynn A. Fussner, Vivek N. Iyer, et al. · Liver Transplantation · 52

Epidemiology and outcome of new-onset atrial fibrillation in the medical intensive care unit

2016 · Perliveh Carrera, Charat Thongprayoon, et al. · Journal of Critical Care · 50

Neurovascular Manifestations of Hereditary Hemorrhagic Telangiectasia: A Consecutive Series of 376 Patients during 15 Years

2016 · W. Brinjikji, V. N. Iyer, et al. · American Journal of Neuroradiology · 48

PDF

Works count: 229

Citation count: 5,121

H-index: 35

I10-index: 78